We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Third Coast Bancshares
TCBX
$690M
| $698K | ﹤0.01% |
18,441
+12,843
| +229% | +$508K |
2025 Q4
1 quarter
|
|
1877
Array Technologies
ARRY
$550M
| $695K | ﹤0.01% |
96,146
-89,170
| -48% | -$825K |
2024 Q3
6 quarters
|
|
1878
Avalo Therapeutics
AVTX
$644M
| $695K | ﹤0.01% |
+46,553
| New | +$728K |
2026 Q1
0 quarters
|
|
1879
Columbus McKinnon
CMCO
$433M
| $694K | ﹤0.01% |
47,739
-69,830
| -59% | -$1.3M |
2025 Q1
4 quarters
|
|
1880
DELISTED
Soleno Therapeutics
SLNO
| $692K | ﹤0.01% |
20,678
+5,631
| +37% | +$221K |
2025 Q3
2 quarters
|
|
1881
Intellia Therapeutics
NTLA
$1.59B
| $690K | ﹤0.01% |
53,795
+40,336
| +300% | +$514K |
2025 Q4
1 quarter
|
|
1882
Cytokinetics
CYTK
$8.89B
| $690K | ﹤0.01% |
10,463
-1,124
| -10% | -$71.4K |
2025 Q4
1 quarter
|
|
1883
PUT
Dell
DELL
$301B
| $689K | ﹤0.01% |
4,200
+900
| +27% | +$120K |
2025 Q1
4 quarters
|
|
1884
AvePoint
AVPT
$3.15B
| $688K | ﹤0.01% |
72,340
+40,646
| +128% | +$458K |
2025 Q2
3 quarters
|
|
1885
Blue Owl Technology Finance Corp
OTF
$4.33B
| $688K | ﹤0.01% |
+55,490
| New | +$707K |
2026 Q1
0 quarters
|
|
1886
Teleflex
TFX
$5.43B
| $687K | ﹤0.01% |
+5,746
| New | +$633K |
2026 Q1
0 quarters
|
|
1887
Sprout Social
SPT
$701M
| $687K | ﹤0.01% |
120,514
+36,208
| +43% | +$279K |
2025 Q2
3 quarters
|
|
1888
DELISTED
Theravance Biopharma
TBPH
| $683K | ﹤0.01% |
42,103
-74,981
| -64% | -$1.33M |
2025 Q3
2 quarters
|
|
1889
Adtran
ADTN
$532M
| $681K | ﹤0.01% |
54,171
-120,503
| -69% | -$1.22M |
2024 Q4
5 quarters
|
|
1890
Owlet
OWLT
$130M
| $679K | ﹤0.01% |
+132,054
| New | +$1.4M |
2026 Q1
0 quarters
|
|
1891
Pony AI Inc
PONY
$2.25B
| $679K | ﹤0.01% |
71,877
-76,284
| -51% | -$1.05M |
2025 Q3
2 quarters
|
|
1892
Daktronics
DAKT
$879M
| $677K | ﹤0.01% |
34,640
-28,121
| -45% | -$642K |
2025 Q4
1 quarter
|
|
1893
Fortrea Holdings
FTRE
$2.16B
| $677K | ﹤0.01% |
+71,839
| New | +$923K |
2026 Q1
0 quarters
|
|
1894
C4 Therapeutics
CCCC
$342M
| $675K | ﹤0.01% |
256,468
+100,370
| +64% | +$236K |
2025 Q1
4 quarters
|
|
1895
ICU Medical
ICUI
$4.18B
| $673K | ﹤0.01% |
+5,208
| New | +$749K |
2026 Q1
0 quarters
|
|
1896
G-III Apparel Group
GIII
$1.22B
| $672K | ﹤0.01% |
24,247
+5,882
| +32% | +$172K |
2025 Q3
2 quarters
|
|
1897
H.B. Fuller
FUL
$2.78B
| $669K | ﹤0.01% |
+10,850
| New | +$665K |
2026 Q1
0 quarters
|
|
1898
Ginkgo Bioworks
DNA
$792M
| $669K | ﹤0.01% |
+109,117
| New | +$908K |
2026 Q1
0 quarters
|
|
1899
DELISTED
AvalonBay Communities
AVB
| $666K | ﹤0.01% |
4,078
-11,695
| -74% | -$2.04M |
2023 Q4
9 quarters
|
|
1900
CALL
JD.com
JD
$37B
| $665K | ﹤0.01% |
22,500
+2,500
| +13% | +$70.7K |
2025 Q4
1 quarter
|
|
Similar funds
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.